| 750558 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
P02.07 Characterization of the tumor immune microenvironment of pediatric posterior fossa A ependymomas |
2021-10-01 |
10.1136/jitc-2021-itoc8.19 |
Lammers J, Calkoen F, Kranendonk M, Federico A, Kool M, Kester L, van der Lugt J |
| 750557 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
P03.04 Novel algorithm discovers up to 35 percent more epitopes translated from non-coding regions in cold tumours |
2021-10-01 |
10.1136/jitc-2021-itoc8.27 |
Bogaert C, Van Oudenhove L, Fant B |
| 750556 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
P08.03 Neoantigen cancer vaccine auguments anti CTLA-4 efficacy |
2021-10-01 |
10.1136/jitc-2021-itoc8.47 |
Palombo F, Salvatori E, Lione L, Compagnone M, Conforti A, Aurisicchio L |
| 750555 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
P01.07 Depletion of CD206high tumour-associated macrophages using a nanoconjugate limits tumour burden & dissemination in metastatic triple negative breast cancer in mice |
2021-10-01 |
10.1136/jitc-2021-itoc8.11 |
Lepland A, Malfanti A, Haljasorg U, Dordevic S, Salumäe L, Peterson P, Teesalu T, Vicent MJ, Scodeller P |
| 750554 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
P08.06 Combining RIG-I-targeted immune activation with CAR T cell therapy induces efficient tumor control in murine pancreatic cancer models |
2021-10-01 |
10.1136/jitc-2021-itoc8.50 |
Senz AM, Formisano SL, Cadilha B, Lorenzini T, Endres S, Kobold S, Schnurr M, König LM |
| 750553 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
P08.04 Successful immunotherapy of the breast cancer metastatic disease in mice using a pharmaceutical TLR4-agonist induces systemic anti-tumor T cell response and long-term T cell memory |
2021-10-01 |
10.1136/jitc-2021-itoc8.48 |
Ushakova E, Lebedeva E, Pichugin A, Ataullakhanov R |
| 750552 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
P01.06 Overweight and obesity as biomarkers for survival outcomes and immune related adverse events undergoing immunotherapy – a systematic review and meta-analysis |
2021-10-01 |
10.1136/jitc-2021-itoc8.10 |
Trinkner P, Günther S, von Bergwelt M, Cordas dos Santos D, Theurich S |
| 750551 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
P01.03 Targeting diaclyglycerol kinase alpha and zeta by self delivering RNAi to optimize tlymphocytes for adoptive therapy of solid tumors |
2021-10-01 |
10.1136/jitc-2021-itoc8.7 |
Herbstritt AS, Maxwell M, Yan D, Cuiffo B, Cardia J, Fricker SP, Noessner E |
| 750550 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
10.02 Genomic HLA homozygosity is frequent in esophageal adenocarcinoma and related to low immunogenicity |
2021-10-01 |
10.1136/jitc-2021-itoc8.2 |
Garcia-Marquez MA, Thelen M, Bauer E, Wennhold K, Lehmann J, Keller D, Gathof B, Maas L, George J, Bruns C, Quaas A, von Bergwelt-Baildon M, Peifer M, Schlößer HA |
| 750549 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
P04.04 Programmed death-ligand 1 positron emission tomography imaging during neoadjuvant (chemo)radiotherapy in esophageal and rectal cancer (PETNEC): a prospective non-randomized open-label single-center pilot study |
2021-10-01 |
10.1136/jitc-2021-itoc8.33 |
Laengle J, Tamandl D, Schmid R, Widder J, Bergmann M, Haug A |
